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Abstract
Conflicting findings exist regarding the link between environmental factors and development of Alzheimer’s disease (AD) in
a variety of transgenic mouse models of AD. In the present study, we investigated the effect of behavioral stress on the
onset and progression of Ab pathology in the brains of TgCRND8 mice, a transgenic mouse model of AD. One group of
TgCRND8 mice was subjected to restraint stress starting at 1 month of age until they were 3 months old, while restraint
stress in the second group started at 4 months of age until they were 6 months old. After 2 months of treatment, no
differences in the soluble, formic acid extracted, or histologically detected Ab deposition in the cortical and hippocampal
levels were found between non-stressed and stressed mice. These results showed that restraint stress alone failed to
aggravate amyloid pathology when initiated either before or after the age of amyloid plaque deposition in TgCRND8 mice,
suggesting that if stress aggravated AD phenotype, it may not be via an amyloid-related mechanism in the TgCRND8 mice.
These findings are indicative that plaque load per se may not be used as a significant criterion for evaluating the effect of
stress on AD patients.
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Introduction
Alzheimer’s disease (AD), the most prevalent form of senile
dementia, is characterized by two major histopathological
hallmarks including Ab plaque and tau-laden neurofibrillary
tangle formation [1]. Although several genetic factors are known
to be involved in early onset of familial AD [2–6], the etiology of
sporadic AD that accounts for the majority of AD cases remains
unclear [7;8]. Epidemiological studies suggest that AD can be
modulated by environmental factors. For example, those who are
prone to psychological distress are more likely to develop AD
[9;10]. Although it is well accepted that both genetic and
environmental factors are likely to trigger the pathogenic pathways
of AD, researchers over the last decade have mainly focused on
studying the genetic contributions in AD [11–13]. Studies have
recently begun to investigate the effect of environmental factors on
neuropathology and cognitive function in transgenic models of AD
[13–16]. In contrast to the clinical observations that environmen-
tal factors play important roles in the complex etiology of AD [17],
contradicting findings from animal models of AD have been
reported. For example, environmental enrichment, such as
increased physical activity, cognitive stimulation, or a combination
of both, has been demonstrated to elicit different outcomes
including a reduction [18–21], no effect [14;22;23], or even an
exacerbation [24;25] in extracellular plaque pathology in animal
models of AD.
Similar to environment enrichment, stress is another important
paradigm that researchers often used to study the association of
environmental factors and AD pathology in AD models. Stress, an
unavoidable condition of human experience including both major
life events and the problems of daily life, is known to affect the
body’s physiology [26;27], immunological response [28] and
endocrine system [29]. The most popular experimental procedure
to induce stress in animals relies on the use of restraint [30], which
has the advantage of being straightforward and painless [30].
The experiments which subjected the mice of AD models to
behavioral stress also yielded inconsistent results in terms of
extracellular plaque pathology. For example, Devi et al [16] found
that stress aggravated b-amyloidogenesis in hippocampus but not
cortex, and in female but not male mice. In contrast, Lee et al [31]
reported that the stress accelerates b-amyloidogenesis in not only
cortex and hippocampus but also both female and male animals.
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Thus, the association of stress and b-amyloidogenesis remains an
unresolved issue and clearly warrants further investigations.
The TgCRND8 mouse model has been demonstrated to
develop a very early and aggressive phenotype, showing onset of
Ab pathology at the age of 3 months [32]. The aim of the present
study was to determine whether restraint stress was able to
accelerate the onset and progression of Ab pathology in this mouse
model by using animals of 1 (before Ab plaque formation) and 4
month-old of age (after Ab plaque formation) [32]. In the previous
studies involved in investigating the effects of restraint stress on
neuropathology of AD, common to all methods of the restraint is
the restriction and immobilization of movement. However, a
number of variations in effecting the restraint have been
published. For example, the treatment duration varies ranging
from a consecutive several days [16] to several months [33]. No
comparative studies of the relative merits favoring any duration
have been reported. In this study, we investigated the effects of two
months of immobilization on the Ab plaque formation in
TgCRND8 mice.
Materials and Methods
Transgenic mice
The generation of TgCRND8 mice has been described
previously [32]. TgCRND8 mice express a transgene incorporat-
ing both the Indiana mutation (V717F) and the Swedish mutations
(K670N/M671L) in the human amyloid-beta protein precursor
(APP) gene. The mice were kept on a C57BL6/J genetic
background. Because many studies indicated that when stressed,
male rodents showed habituation while female ones showed
sensitization [16;34;35], only female mice were used in the current
study. This study was carried out in strict accordance with the
recommendations in Code of Practice for Care and Use of
Animals for Experimental Purposes of Hong Kong. Procedures of
animal handling were approved by the Committee on the Use of
Live Animals for Teaching and Research of the University of
Hong Kong. For sacrificing animals, sodium pentobarbital
anesthesia was used to minimize suffering.
Stress induction
TgCRND8 mice at 1- or 4 month-old were randomly assigned
to either standard housing or restraint stress condition (n = 5).
Standard laboratory cages (33 cm618 cm614 cm) were used for
standard housing. The restraint treatment was performed as
described previously [31]. Briefly, TgCRND8 mice were individ-
ually placed in a well-ventilated plastic tube. Mice were not able to
move forward or backward while in the tube. The mice were
restrained for 6 h per day. After each stress session, the mice were
returned to their normal home environment, in which they were
housed in standard laboratory cages with free access to food and
water. This daily procedure was repeated for a consecutive 2
months.
Thioflavin S Staining
Cross sections of the brains of the animals were incubated in
0.5% thioflavin S (Sigma-Aldrich, St Louis, MO, USA) in 50%
ethanol for 10 min, differentiated twice in 50% ethanol, and
washed in PBS solution. Staining was visualized under a Zeiss
fluorescence microscope (Gottingen, Germany).
Immunohistochemistry
For immunofluorescent staining, cross sections of the brain were
incubated overnight at room temperature with primary antibodies
(Bam-10, 1:3000, Sigma-Aldrich, c-fos, 1:3000, Chemicon and
oxytocin, 1:2000, Penisular laboratories). After rinsing with
0.01 M PBS, they were incubated for 1 h at room temperature
with corresponding secondary antibodies conjugated with Alexa-
488 or 568 (1:800, Molecular Probes, Eugene, USA). The primary
and secondary antibodies were diluted in PBS containing 1%
normal goat serum and 0.2% Triton X-100. The number of c-fos-
immunoreactive nuclei per section was counted in 5 sections per
animal at the level of middle of supraoptic nuclei (SON).
For double staining of c-fos/oxytocin, the sections were first
incubated with two primary antibodies derived from different
species and then the corresponding Alexa 488 or 568-conjugated
secondary antibody (1:800, Molecular probes, Eugene, USA).
Each step was followed by three washes in PBS. Finally, the
sections on gelatin-coated glass slides were coverslipped in
mounting medium (Dako, Denmark). Fluorescent images were
captured with a Zeiss microscope (Gottingen, Germany) equipped
with a Spot digital camera (Diagnostic Instruments, Sterling
Heights, MI, USA).
For light microscopic inspection, spinal cord cross sections were
rinsed three times for 10 min each in PBS. The sections were then
immersed for 30 min in 0.2% H2O2 to inhibit endogenous
peroxidase activity and blocked for 2 h with 5% normal serum in
PBS/0.3% Triton X-100 and incubated with mouse Bam-10
overnight at room temperature. On the second day, the sections
were incubated with secondary antibodies at room temperature.
The sections were processed by the avidin-biotin-peroxidase/3,3-
diaminobenzidine (DAB) method [36]. Each step was followed by
three washes in PBS. The sections were then mounted on gelatin-
coated slides for light microscopic inspection.
Determination of Ab plaque burden
Brains were coronally-sectioned in 30 mm thickness using a
microtome. Plaque deposition levels were examined in paricortex
and hippocampus. Five animals were used in each group for
counting. To avoid bias in quantification of plaque levels, serial
images of 1006 magnification were captured using a Zeiss
microscope equipped with a SPOT camera and SPOT software
(RT Color diagnostic Instrument INC, Michigan, USA) on 6
sections per animal which were 30 mm afar from each other,
starting 1.32 mm from bregma [14]. By using ImageJ software,
pictures were binarized to 8-bit black and white pictures and a
fixed intensity threshold was applied to define the DAB staining.
Measurements were performed for a percentage area covered by
Bam-10 DAB staining without knowing non-stress or stress
treatment.
Measurement of plasma corticosterone
Animals were anaesthetized by using katemine (80 mg/kg) and
xylazine (8 mg/kg). Blood was collected from the heart within
3 min using a heparinized needle. Samples were centrifuged
(2000 rpm for 20 min at 4uC). Plasma aliquots were stored at
280uC until use. The corticosterone level was examined by using
a CorrelateEIA corticosterone kit (Assay Design, USA). Measure-
ments were performed according to the manufacturer’s instruc-
tions.
Assessment of Ab levels
Sandwich Ab ELISA assay was performed as described
previously [37]. Hippocampal tissue was homogenized in Tris-
buffered saline (20 mM Tris and 137 mM NaCl, pH 7.6)
supplemented with protease inhibitors. The formic acid-soluble
Ab was collected, and neutralized with 1 M Tris buffer (pH 11).
The levels of Ab1–40 and Ab1–42 peptides were analyzed using
human b Amyloid Ab1–40 and Ab1–42 Ab colorimetric sandwich
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ELISA kits (Wako Pure Chemical Industries Ltd., Japan)
according to the manufacturer’s instructions.
Statistical analysis
All data were given as means 6 standard error of the mean
(SEM). Data distribution was evaluated and student t test was then
used to test the difference between non-stressed and stressed
groups. A value of p,0.05 was considered statistically significant.
Results
Age-related Ab deposition in the brain of TgCRND8 mice
Consistent with previous studies [32], no Ab plaque was found
in either cortex or hippocampus of TgCRND8 at the age of 1
month (Fig. 1A, Table 1), and Ab plaques could be observable in
either cortex (arrow Fig. 1B, Table 1) or hippocampus (arrow head
in Fig. 1B, Table 1) at the age of 3 months. It was found that Ab
plaques increased with age and abundant plaques were observed
in cortex (arrows in Fig. 1C, Table 1) or hippocampus at the age of
6 months (arrow heads in Fig. 1C, Table 1).
Restraint stress activated hypothalamic neurons in
TgCRND8 mice
To determine whether the restraint treatment induces stress
response on TgCRND8 mice, we examined whether the neurons
in hypothalamus was activated by restraint stress treatment.
Consistent with previous study [38–40], few c-fos, if any, could be
observed in both paraventricular (PVN) (Fig. 2C) and SON
(Fig. 2D and E) of TgCRND8 mice. However, stress induced
intensive c-fos expression in the two nuclei (Fig. 2A and B,
respectively). Quantitative analysis also showed a significant
difference in the number of c-fos immunoreactive nuclei in SON
between the stressed and non-stressed animals (Fig. 2E). Co-
labeling of c-Fos and oxytocin in PVN (Fig. 3A–C) and SON
(Fig. 3E–F) further confirmed that c-fos was induced in the
oxytocin-neurons of hypothalamus. The findings corroborated
that restraint stress was able to induce stress response in
hypothalamus of the experimental mice.
Restraint stress increased the plasma corticosterone level
of TgCRND8 mice
The stress response by the restraint treatment was further
confirmed by the increased plasma corticosterone level of
TgCRND8 mice. The basal levels of circulating corticosterone
in TgCRND8 mice were 69.2612.5 ng/ml at the age of 3 month-
old and 146.5632.1 ng/ml at the age of 6 month-old (Fig. 4).
After the 6 h-2 m stress, the plasma corticosterone levels in
TgCRND8 mice significantly increased to 341.1657.3 and
409676.3 ng/ml, respectively (Fig. 4).
Restraint stress did not influence cortical and
hippocampal amyloid plaque loads
To test whether behavioral stress directly affects the onset and
progression of Ab pathology, TgCRND8 mice at the age of 1 or 4
months were subjected to restraint stress treatment for 6 h daily
for 2 months. Histopathologic analysis indicated that sparse Ab
plaques were detected in the brains of TgCRND8 mice at the age
of 3 months (Fig. 5B). However, the stress did not increase the
number of plaques in either cortex or hippocampus of the brains
of the stressed animals (Fig. 5A). High plaque-load was found in
the brains of the animals at 6 months of stressed mice (Fig. 5C),
but the number of Ab plaques in either cortex or hippocampus of
stressed mice (Fig. 5C) did not exceed that in the non-stressed mice
(Fig. 5D). Quantitative analysis also showed no significant
difference in plaque load in either cortex or hippocampus in
TgCRND8 mice at the ages of 3 (Fig. 5E) and 6 (Fig. 5F) months
between the stressed and non-stressed animals.
Restraint stress did not affect Ab levels in hippocampus
The findings of unchanged Bam10-positive Ab deposits were
further corroborated by Ab ELISA analysis in hippocampus of the
Figure 1. Cross sections of the brains were stained with
Thioflavin S staining in TgCRND8 mice at the age of 1 (A), 3
(B) and 6 (C) months. Scale bar = 100 mm.
doi:10.1371/journal.pone.0053480.g001
Table 1. The number of Thioflavin S-positive plaques/section
in the brains of TgCRND8 mice at the age of 1, 3 or 6 month-
old.
Age of animals Number of plaques in the brain/section
1 month-old 0
3 month-old 1964.5
6 month-old 212629
doi:10.1371/journal.pone.0053480.t001
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brains. Soluble Ab was first extracted with lysis buffer (Sigma-
Aldrich, Poole, UK) (Fig. 6A and C), and the remaining Ab was
pelleted at 100,000 g and extracted with 70% formic acid (Fig. 6B
and D). In either lysis buffer or formic acid extractable fraction,
neither Ab1–40 nor Ab1–42 was found to be increased in the
restraint stress mice when compared to their non-stressed controls.
Discussion
Despite an intensive activation of the neurons of hypothalamic
PVN and SON and marked increased levels of corticosterone, the
stress marker, under restraint stress, this treatment paradigm failed
categorically to modify Ab pathology in the brains of TgCRND8
mice with treatment being initiated at the age of either 1 or 4
months. In this study, we applied 1- and 4-month-old TgCRND8
animals since the animals at the age of 1 month were not old
enough to have amyloid plaque pathology in cortex and
hippocampus, whereas the animals at the age of 4 month had
an observable amyloid plaque pathology in their brains. These
results indicate that the restraint stress failed to accelerate not only
the onset of amyloid plaque pathology, but also its progression.
These results were in stark contrast to those of Lee et al [31] who
found the aggravation of Ab pathology in restraint-treated Tg2576
mice despite both their and our groups used the same method to
restrict the movement of animals. Both groups placed the animals
in a plastic tube instead of other methods, e.g. taping the limbs of
animals to a board or tie them to pads. Differences between the
previous reports and the present study include: 1) intensity and
duration of restraint, and 2) mouse line of AD model. Indeed,
Figure 2. Restraint stress activated hypothalamic neurons in
TgCRND8 mice. A–D: Cross sections of the brains stained with c-fos
immunohistochemical staining in PVN (A and C) and SON (B and D) of
TgCRND8 mice at the age of 4 months undergone restraint stress (A
and B) and non-stress treatment (C and D). E: Quantitative analysis of
number of c-fos immunoreactive nuclei in SON of stressed and non-
stressed TgCRND8 mice. * indicates statistical differences when
compared with their age-matched non-stressed controls at p,0.01.
Scale bar = 150 mm.
doi:10.1371/journal.pone.0053480.g002
Figure 3. c-fos was induced in oxytotic neurons. A–C: Double
staining of c-fos (red)/oxytocin (green) in paraventricular (PVN). D–F:
Double staining of c-fos (red)/oxytocin (green) in supraoptic nuclei
(SON). Scale bar = 75 mm.
doi:10.1371/journal.pone.0053480.g003
Figure 4. Plasma corticosterone levels in the stressed TgCRND8
mice increased compared with that in their non-stressed
controls at the age of 3 and 6 month-old. * indicates statistical
differences when compared with their age-matched non-stressed
controls at p,0.01.
doi:10.1371/journal.pone.0053480.g004
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under certain circumstances, restraint will not produce a stress
response which may be due to insufficient intensity and duration of
the restraint [30]. In the study of Lee et al [31], AD mice were
exposed to restraint for 2 h daily for consecutive 16 days.
However, the animals in the present study were subjected to
restraints for 6 h daily for 2 months, and the intensity of treatment
was stronger and duration of treatment is much longer than those
in the previous study. Thus, difference in intensity and duration of
restraint seemed not to be the reason for the observed difference.
To further confirm that the restraint produced a stress response in
the restrained mice, we examined the global consequence of
restraint stress in hypothalamus of neuroendocrine system [38–
42], and found that restraint stress induced activation of oxytocin
neurons in PVN and SON of hypothalamus as evidenced by
induction of c-fos expression. It has been suggested that oxytocin
may regulate stress-induced corticotropin-releasing hormone gene
expression [38].
The different genotypes of the AD models may account for the
different results seen in the studies of Lee et al and ours. In line
with this, discrepancies in the reported results about studying the
effects of environmental enrichment on Ab pathology among
different research groups have been reported. For example, on the
one hand, environmental enrichment attenuates Ab plaques in
TgCRND8 mice [19], on the other hand, environmental
enrichment exacerbates amyloid plaque formation in APP/PS1
transgenic mice [24]. More surprisingly, Cotel and co-workers
[14] have recently found that environmental enrichment has no
effect on Ab load in APP/PS1KI mice. The conflicting findings
might be attributed, at least partially, to the use of different
transgenic models of AD. Our finding together with the those of
Lee et al [31] may confirm the hypothesis that interactions
between environmental risk factors and genetic background may
influence the onset and progression of sporadic AD [15].
It has also been shown that effect of behavioral stress on beta-
amyloidogenesis is sex-specific [16]. Devi et al [16] reported that
behavioral stress increased plaque burden in the hippocampus of
female 56FAD mice but not in the male 56FAD mice. However,
the difference between our findings and those of Devi et al cannot
be attributed to the difference in gender as we only used
TgCRND8 female mice to evaluate the effect of restraint stress
on Ab pathology.
Our present study which showed the restraint stress failed to
accelerate the onset and progression of Ab pathology in
TgCRND8 does not necessarily mean that our results are conflict
with the clinical observations that stress may be an important
contributor to the onset and development of AD [9;10]. Indeed,
amyloid is only one part of a multi-factorial disease processes of
AD incorporating a wealth of disease-causing factors [43]. Under
certain circumstances, factors that either aggravate or attenuate
AD-like pathology may not act via Ab-related mechanisms. For
example, Jeong et al [44] have found that in their stress system,
memory function was impaired under stress even though Ab
deposition was unchanged. Similarly, Jankowsky et al [25] have
shown that environment enrichment has a protective effect on
cognitive function regardless of exacerbation in Ab deposition.
Our results provide evidence to support the notion that plaque
load per se may not represent a significant outcome measure for
evaluating the therapeutic effect on AD patients.
It is worth mentioning that the psychological and physiological
changes associated with restraint appear to result from the distress
and aversive nature of having to remain immobile, rather than
immobilization itself [30]. In our study, we observed that
restrained animals kept struggling even in a restrainer with a very
limited space (See Video S1). The struggling of the mice increased,
in a sense, physical activity. If so, this might explain why the
restraint stress failed to aggravate the Ab pathology in TgCRND8
mice, for it has been shown that higher levels of physical activity
can attenuate Ab pathology [20;21]. The physical activity might
counteract the effect of the psychological stress on Ab pathology in
the present study. The evidence that increased physical activity as
well as enriched housing can reverse the effect of stress on the
progression of AD in a mouse model of AD also lend support to
the above explanation [44]. The implication of our findings is that
even if we constantly experience various types of stress (in fact, we
are invariably and unavoidably confronted with stressful circum-
stances throughout life), some forms of effective interventions, e.g,
increasing physical activity, can always be applied to confront and
offset the adverse effects of stress on the onset and progression of
AD pathology.
Figure 5. Restraint stress did not influence cortical and
hippocampal amyloid plaque loads. A–D, Cross sections of the
brains stained with bam-10 immunohistochemical staining in TgCRND8
mice at the age of 3 (A, B) or 6 months (C, D) under stress (A, C) and
non-stress (B, D). E–F, Quantitative analysis of Ab deposit burden in
either cortex or hippocampus in TgCRND8 mice at the age of 3 (E) or 6
months (F) under stress or non-stress. Scale bar = 300 mm.
doi:10.1371/journal.pone.0053480.g005
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Supporting Information
Video S1 The restrained TgCRND8 mice are struggling
in the plastic tube restrainer.
(WMV)
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